Skip to main content

Advertisement

SpringerLink
Log in

Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders

  • Neurology and Preclinical Neurological Studies - Review Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Sleep disturbances in Parkinson’s disease and parkinsonism (such as atypical parkinsonian disorders like multiple system atrophy, progressive supranuclear palsy, dementia with Lewy bodies and corticobasal degeneration) are multifactorial and as such treatment needs to be tailored to the specific patient case and sleep dysfunction. One also has to consider drug-related effects on sleep architecture. This article provides an overview of the therapeutic options for nocturnal problems in Parkinson`s disease and atypical parkinsonian disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arnulf I (2005) Excessive daytime sleepiness in parkinsonism. Sleep Med Rev 9(3):185–200

    Article  PubMed  Google Scholar 

  • Arnulf I, Merino-Andreu M et al (2005) REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 28(3):349–354

    PubMed  Google Scholar 

  • Aurora RN, Zak RS et al (2010) Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 6(1):85–95

    PubMed Central  PubMed  Google Scholar 

  • Bhidayasiri R, Truong DD (2012) Therapeutic strategies for nonmotor symptoms in early Parkinson’s disease: the case for a higher priority and stronger evidence. Parkinsonism Relat Disord 18(Suppl 1):S110–S113

    Article  PubMed  Google Scholar 

  • Boeve BF, Silber MH et al (2001) Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 16(4):622–630

    Article  CAS  PubMed  Google Scholar 

  • Boeve BF, Silber MH et al (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130(Pt 11):2770–2788

    Article  CAS  PubMed  Google Scholar 

  • Chaudhuri KR (2002) The basis for day and night-time control of symptoms of Parkinson’s disease. Eur J Neurol 9(Suppl 3):40–43

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464–474

    Article  CAS  PubMed  Google Scholar 

  • Chaudhuri KR, Pal S et al (2002) The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73(6):629–635

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Epstein LJ, Kristo D et al (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5(3):263–276

    PubMed  Google Scholar 

  • Fantini ML, Gagnon JF et al (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10):1418–1420

    Article  CAS  PubMed  Google Scholar 

  • Findley L, Smith C et al (2000) Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 161(3 Pt 1):857–859

    CAS  PubMed  Google Scholar 

  • Gagnon JF, Postuma RB et al (2006) Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 5(5):424–432

    Article  PubMed  Google Scholar 

  • Gaig C, Iranzo A (2012) Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep 12(2):205–217

    Article  PubMed  Google Scholar 

  • Gama RL, Tavora DG et al (2010) Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy—a comparative study. Parkinsonism Relat Disord 16(4):275–279

    Article  PubMed  Google Scholar 

  • Garcia-Borreguero D, Ferini-Strambi L et al (2012) European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 19(11):1385–1396

    Article  PubMed  Google Scholar 

  • Ghorayeb I, Yekhlef F et al (2002) Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 72(6):798–800

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hattori Y, Hattori T et al (2003) Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy. No To Shinkei 55(12):1053–1056

    PubMed  Google Scholar 

  • Hauw JJ, Hausser-Hauw C et al (2011) Neuropathology of sleep disorders: a review. J Neuropathol Exp Neurol 70(4):243–252

    Article  PubMed  Google Scholar 

  • Hogl B, Saletu M et al (2002) Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25(8):905–909

    CAS  PubMed  Google Scholar 

  • Iranzo A (2005) Management of sleep-disordered breathing in multiple system atrophy. Sleep Med 6(4):297–300

    Article  PubMed  Google Scholar 

  • Iranzo A, Santamaria J (1999) Bisoprolol-induced rapid eye movement sleep behavior disorder. Am J Med 107(4):390–392

    Article  CAS  PubMed  Google Scholar 

  • Iranzo A, Santamaria J et al (2000) Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 356(9238):1329–1330

    Article  CAS  PubMed  Google Scholar 

  • Iranzo A, Santamaria J et al (2004) Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 63(5):930–932

    Article  CAS  PubMed  Google Scholar 

  • Iranzo A, Molinuevo JL et al (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5(7):572–577

    Article  PubMed  Google Scholar 

  • Iranzo A, Santamaria J et al (2009) The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 13(6):385–401

    Article  PubMed  Google Scholar 

  • Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540–545

    CAS  PubMed  Google Scholar 

  • Kimura K, Tachibana N et al (1997) Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration. Sleep 20(10):891–894

    CAS  PubMed  Google Scholar 

  • Knie B, Mitra MT et al (2011) Excessive daytime sleepiness in patients with Parkinson’s disease. CNS Drugs 25(3):203–212

    Article  CAS  PubMed  Google Scholar 

  • Kuzniar TJ, Morgenthaler TI et al (2009) Effects of continuous positive airway pressure on stridor in multiple system atrophy-sleep laryngoscopy. J Clin Sleep Med 5(1):65–67

    PubMed Central  PubMed  Google Scholar 

  • Larsen JP, Tandberg E (2001) Sleep disorders in patients with Parkinson’s disease: epidemiology and management. CNS Drugs 15(4):267–275

    Article  CAS  PubMed  Google Scholar 

  • Montplaisir J, Petit D et al (1997) Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology 49(4):999–1003

    Article  CAS  PubMed  Google Scholar 

  • Moreno-Lopez C, Santamaria J et al (2011) Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol 68(2):223–230

    Article  PubMed  Google Scholar 

  • Morrison I, Frangulyan R et al (2011) Beta-blockers as a cause of violent rapid eye movement sleep behavior disorder: a poorly recognized but common cause of violent parasomnias. Am J Med 124(1):e11

    Article  PubMed  Google Scholar 

  • Olson EJ, Boeve BF et al (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123(Pt 2):331–339

    Article  PubMed  Google Scholar 

  • Ondo WG, Fayle R et al (2005) Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 76(12):1636–1639

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ondo WG, Perkins T et al (2008) Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Arch Neurol 65(10):1337–1340

    Article  PubMed  Google Scholar 

  • Pahwa R, Stacy MA et al (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68(14):1108–1115

    Article  CAS  PubMed  Google Scholar 

  • Pao WC, Boeve BF et al (2013) Polysomnographic findings in dementia with Lewy bodies. Neurologist 19(1):1–6

    PubMed Central  PubMed  Google Scholar 

  • Poewe WH, Rascol O et al (2007) Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson’s disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurol 6(6):513–520

    Article  CAS  PubMed  Google Scholar 

  • Poewe W, Rascol O et al (2011) Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology 77(8):759–766

    Article  CAS  PubMed  Google Scholar 

  • Politis M, Wu K et al (2010) Parkinson’s disease symptoms: the patient’s perspective. Mov Disord 25(11):1646–1651

    Article  PubMed  Google Scholar 

  • Ray Chaudhuri K, Martinez-Martin P et al (2012) Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson’s disease. Eur J Neurol 19(1):105–113

    Article  CAS  PubMed  Google Scholar 

  • Sasai T, Matsuura M et al (2013) Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19(2):153–157

    Article  PubMed  Google Scholar 

  • Schapira AH, Barone P et al (2011) Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology 77(8):767–774

    Article  CAS  PubMed  Google Scholar 

  • Seppi K, Weintraub D et al (2011) The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):S42–S80

    Article  PubMed Central  PubMed  Google Scholar 

  • Shimohata T, Shinoda H et al (2007) Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 64(6):856–861

    Article  PubMed  Google Scholar 

  • Shimohata T, Ozawa T et al (2008) Frequency of nocturnal sudden death in patients with multiple system atrophy. J Neurol 255(10):1483–1485

    Article  CAS  PubMed  Google Scholar 

  • Shimohata T, Nakayama H et al (2012) Daytime sleepiness in Japanese patients with multiple system atrophy: prevalence and determinants. BMC Neurol 12:130

    Article  PubMed Central  PubMed  Google Scholar 

  • Silber MH, Levine S (2000) Stridor and death in multiple system atrophy. Mov Disord 15(4):699–704

    Article  CAS  PubMed  Google Scholar 

  • Stocchi F, Vacca L et al (2001) Sleep disorders in Parkinson’s disease. Adv Neurol 86:289–293

    CAS  PubMed  Google Scholar 

  • Suzuki M, Saigusa H et al (2010) Multiple system atrophy manifesting as complex sleep-disordered breathing. Auris Nasus Larynx 37(1):110–113

    Article  PubMed  Google Scholar 

  • Trenkwalder C, Kies B et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26(1):90–99

    Article  PubMed Central  PubMed  Google Scholar 

  • Trenkwalder C, Kies B et al (2012) Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: results from a 1-year, open-label extension of the RECOVER study. Basal Ganglia 2:79–85

    Article  Google Scholar 

  • Wilson SJ, Nutt DJ et al (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 24(11):1577–1601

    Article  CAS  PubMed  Google Scholar 

  • Yamaguchi M, Arai K et al (2003) Laryngeal stridor in multiple system atrophy. Eur Neurol 49(3):154–159

    PubMed  Google Scholar 

  • Yamauchi K, Takehisa M et al (2003) Levodopa improved rapid eye movement sleep behavior disorder with diffuse Lewy body disease. Gen Hosp Psychiatry 25(2):140–142

    Article  PubMed  Google Scholar 

  • Zesiewicz TA, Sullivan KL et al (2010) Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74(11):924–931

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This review presents independent research funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Author information

Authors and Affiliations

  1. Department of Neurology, National Parkinson Foundation International Centre of Excellence, King’s College Hospital and King’s College, 9th floor Ruskin Wing, Denmark Hill, London, SE5 9RS, UK

    Lisa Klingelhoefer, Elisaveta Sokolov & K. Ray Chaudhuri

  2. Department of Neurology, Technical University Dresden, Fetscherstraße 74, Dresden, Germany

    Lisa Klingelhoefer

Authors
  1. Lisa Klingelhoefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisaveta Sokolov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Ray Chaudhuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa Klingelhoefer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klingelhoefer, L., Sokolov, E. & Chaudhuri, K.R. Therapeutic options for nocturnal problems in Parkinson’s disease and atypical parkinsonian disorders. J Neural Transm 121 (Suppl 1), 25–31 (2014). https://doi.org/10.1007/s00702-014-1202-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-014-1202-6

Keywords

Search

Navigation